drugset / Trial / NCT01590901

Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects

NCT01590901

Phase 1 Completed 12 enrolled Otsuka Beijing Research Institute
NaSingle-groupOpen-labelSupportive care

Summary

The Objectives of this study is to evaluate the pharmacokinetics and safety of multiple oral doses of probucol in healthy male subjects.

Timeline

Start
2012-02
Primary completion
2012-04
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Probucol Small molecule 250 mg Oral

Indications

No indication recorded.